In This Section

Post-COVID-19 CLL Resources

Managing chronic lymphocytic leukemia (CLL) can be challenging, even under normal circumstances. But in this unprecedented era of COVID-19, the challenges have multiplied. The patient resources below—brought to you by our partner, The Patient Empowerment Network—feature oncology leaders addressing the questions patients most frequently ask since the pandemic began.

CLL and COVID-19
COVID-19 Vaccination
Office Appointments/Telemedicine
  • How Can CLL Patients Take Advantage of Telemedicine? At the dawn of the global pandemic, many providers expanded their telemedicine options so patients can avoid in-person visits. Steven Coutre, MD, a professor of medicine in the Hematology Department at Stanford University Medical Center, explains how this approach can benefit people with CLL.
  • CLL TelemEDucation Empowerment Resource Center This one-of-a-kind resource center educates the CLL community on the practical usage of telemedicine tools to humanize patient and provider experiences.
  • Office Visit Planners for CLL Patients and Care Partners Appointments with your physician can be overwhelming. To optimize them, arrive organized and prepared to take notes. This downloadable office visit planner can help guide patients and their caregivers from their first office visit to their follow-up appointments.
  • Ask the Expert The Ask the Expert program is a live-streamed webinar series in which world-renowned cancer experts go online to answer a variety of questions from patients and their care partners.
  • CLL 101 This free, virtual, online patient course can help anyone struggling with a recent diagnosis of CLL become empowered through knowledge and support.
Clinical Trials
  • Could a Clinical Trial Be Your Best Treatment Option? Matthew Davids, MD, associate director of the CLL Center at Dana-Farber Cancer Institute, explains the clinical trial process and what’s involved in patient participation.
  • CLL Clinical Trials Explained What are the phases of clinical trials in CLL research, and what happens during each phase? Anthony Mato, MD, director of the CLL Program at Memorial Sloan Kettering Cancer Center, explains these phases and the criteria for trial selection.
  • Should You Discuss a CLL Clinical Trial with Your Doctor? Susan O’Brien, MD, a hematology-oncology specialist at Chao Family Comprehensive Cancer Center, explains why patients with CLL should consider a clinical trial and the role trials play in treatment and care.
  • Patient-to-Patient Diverse Clinical Trial Profiles Program The goal of this program is to bridge the gap between patients who have participated in clinical trials and patients who are interested in learning more about them.
  • You’re Not a Guinea Pig: Understanding Clinical Trial Participation Brian Hill, MD, director of the Lymphoid Malignancies Program at Cleveland Clinic, explains the clinical trial process and addresses common patient fears and misconceptions.
  • Clinical Trial Mythbusters Program This program, run by patients for patients and their families and caregivers, is a live online series that gives patients the chance to actively participate in discussions, ask questions, and get answers from a panel of experts.

Our Partners

CLL Society LogoPatient Empowerment Network Logo 

Our Supporters


Funding & support provided by AbbVie.